Press release
Preimplantation Genetic Diagnosis Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025
Preimplantation genetic diagnosis (PGD) is the genetic profiling of the pre implantable embryos and oocytes before their implantation. The preimplantation genetic diagnosis is similar to that of the parental diagnosis in case of screening for a particular genetic disease. The PGD is advantageous in a way that it helps to avoid the selective pregnancy termination by development and growth of healthy fetus. PGD serves as an addendum to assisted reproductive technology. The preimplantation genetic diagnosis is required in vitro fertilization, in order to obtain oocytes from the embryos for the genetic evaluation of diseased or disease free condition. In simpler terms, the preimplantation genetic diagnosis is technique that is used to identify embryos at risk. The process involves DNA analysis, to figure out mutations or previous records of genetic or chromosomal disorders in the family, with the help of a procedure known as preimplantation genetic profiling.Growing rates in birth defects creating opportunities for expansion of the global preimplantation genetic diagnosis market
A vast data is available reporting birth defects as well as infant mortality. According to World Health Organization (WHO) and March of Dimes (MOD) joint report in 2013, the prevalence of birth defects in India is 61 to 70 per 1000 live births. The report also mentions that, 70% of these birth defects are preventable giving opportunities for the growth preimplantation genetic diagnosis market. Scientific report in the Nature journal states that, 7.9 million infants accounting up to 6% of the worldwide births are born with serious birth defects, out of which more than 50% defects are unknown. These defects may be due to chromosomal abnormalities that could be investigated using preimplantation genetic diagnosis preventing defective births and propelling the global market.
The global preimplantation genetic diagnosis market is segmented on the basis of test types and geographical regions.
Request For Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/698
On the basis of test types:
Chromosomal Abnormalities
Gender Selection
X- Linked Diseases
Aneuploidy
Single Gene Disorders
Others
The chromosomal abnormality segment has witnessed a huge adoption in the global PGD market. This owes to rise in hereditary, genetic, and chromosomal diseases. However, stringent regulations abiding to restriction of gender selection are obstructing the market growth.
Regional growth engines of the global preimplantation genetic diagnosis market
Based on the geographical segmentation, the global preimplantation genetic diagnosis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe is dominating the market attributing to increase in number of late pregnancies, which are mostly expected to be IVFs. Additionally, liberties in the regulations of various countries in Europe has added potential avenues to employ aneuploidy screening thereby making it the top shareholder of the global preimplantation genetic diagnosis market. However, Asia Pacific is expected to witness fastest growth in the forecast years owing to advancements in reproductive healthcare facilities and rising revenue generation. Chinese regulatory bodies volunteering to monitor reproductive challenges in the country and encourage adoption of services to solve the challenges may propel the market growth in China.
Increasing awareness among the population regarding prevention of genetic diseases and reproduction health propelling the global preimplantation genetic diagnosis market
The primary reason to boost the market growth is increasing awareness among people to undergo diagnostic tests in order to prevent birth defects. According to the National Institutes of Health (NIH), which aims for biomedical and public health research, about 50% children are affected by rare diseases. These diseases may include chromosomal defects as well as hereditary disorders. Several other factors contributing to the global preimplantation genetic diagnosis market growth include, high demand of people seeking for in vitro fertilization treatments and advancements in the PGF availing diagnosis of diseases such as cancer and minor disabilities such as deafness. However, ethical issues related to sex determination and stringent regulations regarding sex determination and sex differentiation could hinder the growth of the market.
The key players operating the lbal preimplantation genetic diagnosis market include Abbott Laboratories, Illumina, Inc., Natera Inc., PerkinElmer, Inc., F. Hoffman-La-Roche Ltd, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Inc., Reproductive Genetics Institute and Genea Ltd. These players are consistently involved in enhancing efficiency of the diagnosis process providing better healthcare solutions to the global population.
Ask For the Discount@
https://www.coherentmarketinsights.com/insight/request-discount/698
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preimplantation Genetic Diagnosis Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025 here
News-ID: 760698 • Views: …
More Releases from Clinical Diagnostic Report By CMI

Sepsis Diagnostic Market-Global Industry Insights, Trends, Outlook
Sepsis is life threatening complication caused due to the infection, which can result into organ failure, tissue damage, and ultimately lead to death if left untreated. If sepsis progresses to septic shock, it cause sudden drop in blood pressure and may leads to death of patient. Sepsis occurs due the infection in any part of the body. However the most common site of infections leading to the sepsis are lungs,…
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated…

Enteric Disease Testing Market - Global Industry Insights 2025
Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five…

Hospital Acquired Disease Testing Market to Surpass US$ 2.7 Billion by 2025 Glob …
Hospital acquired Disease Testing – Hospital or Mortuary
Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients occurred due to adverse reaction caused by infectious toxin agents under medical care and were absent at the time of admission. Hospitals acquired infections results in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and increase mortality rate. Pathogens responsible for nosocomial infections include viruses, fungal parasites, and bacteria.
Hospital acquired…
More Releases for Gene
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market
Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Gene editing or Genome editing is…
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product…